Fundz

Enliven Appoints Rick Fair as Chief Executive Officer

PUBLIC · ELVNDec 11, 2025

Position

President

Company

Enliven Therapeutics

Rick Fair
rick.fair@enliventherapeutics.com
BurlingameBiotechnologyHealthcareHealth CareScience And EngineeringTherapeutics

Description

Enliven Therapeutics, Inc. has announced the appointment of Rick Fair as its new Chief Executive Officer, effective December 11, 2025. This transition follows the former CEO, Sam Kintz, assuming the role of Head of Pipeline, and reflects the company's commitment to advancing its clinical stage trials.

Quick answer

Enliven Appoints Rick Fair as Chief Executive Officer (December 11, 2025). Enliven Therapeutics is based in Burlingame, California, United States.

Who is the new President at Enliven Therapeutics?
Enliven Therapeutics named Rick Fair President, announced December 11, 2025.
What did Enliven Therapeutics announce on December 11, 2025?
Enliven Therapeutics, Inc. has announced the appointment of Rick Fair as its new Chief Executive Officer, effective December 11, 2025. This transition follows the former CEO, Sam Kintz, assuming the role of Head of Pipeline, and reflects the company's commitment to advancing its clinical stage trials.
What does Enliven Therapeutics do?
Enliven Therapeutics is a biopharmaceutical company focused on the discovery and development of small molecule inhibitors to help patients with cancer live not only longer, but better.
Where is Enliven Therapeutics based?
Enliven Therapeutics is based in Burlingame, California, United States.
Which similar companies made leadership changes around the same time?
Ovid Therapeutics (December 2, 2025), BioCardia (November 24, 2025), MindImmune Therapeutics (November 24, 2025) and Damora Therapeutics, Inc. (January 6, 2026) also announced leadership changes within 45 days of Enliven Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Healthcare and Science And Engineering

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Enliven Therapeutics, and when

A new leader at Enliven Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Enliven Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Enliven Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Enliven Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Enliven Therapeutics

Location

205 Park Road

Burlingame, California, United States

About

Enliven Therapeutics is a biopharmaceutical company focused on the discovery and development of small molecule inhibitors to help patients with cancer live not only longer, but better. Enliven aims to address existing and emerging unmet needs with a precision oncology approach that improves survival and enhances overall patient well-being. Enliven’s discovery process combines deep insights from clinically validated biological targets and differentiated chemistry to design potentially first-in-class or best-in-class therapies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Enliven Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Rick
Likely contact at this company
••••••••@••••••••

See Rick's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Enliven Therapeutics's next move

Learn about Strategic plan

Enliven Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.